this went down to 13 bucks per share.
You look at the numbers that just came out for continuing operations, plus the fact they expect to grow revs q/q (not y/y) by 12 percent. Do that every quarter and it's a 58 percent annual gain. Why not assume that figure as we have not yet been provided with 2009 numbers.
So this company is still growing near 60 percent, hasn't recognized a dime from the HPV acquisition and is still trading at shockingly low multiples before or after convertible offerings dilution - but that money raised will likely be turned into cash flow far above the negotiated interest rate. So it's fair to take non-gaap earnings of .67 and assume .77, .88 and 1.00 earnings over the next 3 quarters, plus the recent one announced today.
3.32 earnings x 10 Forward PE, now how about 20 forward PE - so where does that leave us? How about a current 15x PE? Seems very conservative right? But do you know where that would take us?
Dave
Dave